Articles

These drug companies are running clinical trials for Alzheimer's drugs. The cure is worth billions, so these are the drug stocks to watch. More

Nio reportedly plans to build a new 40 gigawatt hour battery plant that will manufacture cylindrical batteries. More

For investors in index ETFs such as the Invesco QQQ Trust, today's inflation reading provided another hit to valuations across the board. More

The release of January PCE Price Index has investors in selling mode today, as higher interest rates are being priced into the market. More

NVDA stock saw a sharp and unexpected upturn even as sales declined, thanks to AI hype. The news is souring retail traders' puts. More

These dividend stocks boast both impressive growth profiles and reliable dividend income for 2023 and the long-term. More

QS stock entered double-digit territory after QuantumScape released its quarterly results, and that's just the start of a much bigger rally. More

Subscriber Sign in